Loading…
Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo
The pedunculopontine nucleus (PPN) has long been known to be part of the reticular activating system (RAS) in charge of arousal and REM sleep. We previously showed that in vitro exposure to a HDAC Class I and II mixed inhibitor (TSA), or a specific HDAC class IIa inhibitor (MC 1568), decreased PPN g...
Saved in:
Published in: | Neuropharmacology 2020-03, Vol.165, p.107922-107922, Article 107922 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763 |
---|---|
cites | cdi_FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763 |
container_end_page | 107922 |
container_issue | |
container_start_page | 107922 |
container_title | Neuropharmacology |
container_volume | 165 |
creator | Bisagno, Veronica Bernardi, Maria Alejandra Sanz Blasco, Sara Urbano, Francisco J. Garcia-Rill, Edgar |
description | The pedunculopontine nucleus (PPN) has long been known to be part of the reticular activating system (RAS) in charge of arousal and REM sleep. We previously showed that in vitro exposure to a HDAC Class I and II mixed inhibitor (TSA), or a specific HDAC class IIa inhibitor (MC 1568), decreased PPN gamma oscillations. Given the lack of information on systemic in vivo treatments on neuronal synaptic properties, the present study was designed to investigate the systemic effect of HDAC inhibitors (HDACi) on PPN rhythmicity. Rat pups were injected (acute, single dose) with TSA (4 or 20 mg/kg), MC1568 (4 or 20 mg/kg), or MS275 (20 or 100 mg/kg). Our results show that MC1568 (20 mg/kg) reduced mean frequency of PPN oscillations at gamma band, while increasing mean input resistance (Rm) of PPN neurons. For TSA (4 and 20 mg/kg), we observed reduced mean frequency of oscillations at gamma band and increased mean Rm of PPN neurons. Systemic administration of 20 mg/kg MC1568 and TSA effects on Rm were washed out after 60 min of in vitro incubation of PPN slices, suggesting an underlying functional recovery of PPN calcium-mediated gamma band oscillations over time. In addition, at a lower dose, 4 mg/kg, MC1568 and TSA induced higher mean amplitude gamma oscillations. Blocking HDAC class I might not have deleterious effects on gamma activity, but, more importantly, the inhibition of HDAC class I (at 100 mg/kg) increased gamma band oscillations. In conclusion, the present results in vivo validate our previous findings in vitro and further expand information on the effects of HDAC inhibition on PPN rhythmicity. PPN neurons require normal activity of HDAC class IIa in order to oscillate at gamma band.
Red arrows represent statistical significant inhibition. Blue arrows represent statistical significant enhancement. ~ Represents absence of change.Our findings suggest that gamma oscillations in the PPN are finely tuned in vivo by the activity of HDAC class IIa. Sustained blocking of HDAC IIa blunted gamma band oscillations of PPN neurons. Blocking HDAC class I showed higher gamma band amplitudes. In conclusion, systemic administration of HDAC inhibitors might have either negative or positive effects on PPN rhythmicity depending of dose and group of HDAC affected. [Display omitted]
•HDAC class IIa inhibitors (acutely, i.p.) blunted PPN oscillations at gamma band.•HDAC class I inhibitors (100 mg/kg; i.p.) increased PPN gamma band oscillations.•We suggest the existence of a phy |
doi_str_mv | 10.1016/j.neuropharm.2019.107922 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7029427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390819304939</els_id><sourcerecordid>2336246880</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763</originalsourceid><addsrcrecordid>eNqFUctOwzAQtBAIyuMXkI9cUvxSbF-QoDyKQMABzpbjbKirNC52Gql_j1F5njjZHs_O7s4ghCkZU0LL0_m4g1UMy5mNizEjVGdYasa20IgqyQtJSrGNRoQwVXBN1B7aT2lOCBGKql20x6lmXJblCN1d-qaBCF3vbYsh312fcGjw9PJ8gn0385XvQ8xQh5-eHnBIzretzdAaW9f7wffrTMODH8Ih2mlsm-Do8zxAL9dXz5Npcf94czs5vy-ckLovHJUanIKKKyugcrwSlW5q0E0jtVacaGBSVpo5Kkh-cKap0KJmdS1Ay5IfoLON7nJVLaB2efhoW7OMfmHj2gTrzd-fzs_MaxiMJEwLJrPAyadADG8rSL1Z-OQg79VBWCXDOC-ZKJUimao2VBdDShGa7zaUmI8szNz8ZGE-sjCbLHLp8e8xvwu_zM-Eiw0BslmDh2iyudA5qH3MMZg6-P-7vAOJXqF0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2336246880</pqid></control><display><type>article</type><title>Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo</title><source>ScienceDirect Journals</source><creator>Bisagno, Veronica ; Bernardi, Maria Alejandra ; Sanz Blasco, Sara ; Urbano, Francisco J. ; Garcia-Rill, Edgar</creator><creatorcontrib>Bisagno, Veronica ; Bernardi, Maria Alejandra ; Sanz Blasco, Sara ; Urbano, Francisco J. ; Garcia-Rill, Edgar</creatorcontrib><description>The pedunculopontine nucleus (PPN) has long been known to be part of the reticular activating system (RAS) in charge of arousal and REM sleep. We previously showed that in vitro exposure to a HDAC Class I and II mixed inhibitor (TSA), or a specific HDAC class IIa inhibitor (MC 1568), decreased PPN gamma oscillations. Given the lack of information on systemic in vivo treatments on neuronal synaptic properties, the present study was designed to investigate the systemic effect of HDAC inhibitors (HDACi) on PPN rhythmicity. Rat pups were injected (acute, single dose) with TSA (4 or 20 mg/kg), MC1568 (4 or 20 mg/kg), or MS275 (20 or 100 mg/kg). Our results show that MC1568 (20 mg/kg) reduced mean frequency of PPN oscillations at gamma band, while increasing mean input resistance (Rm) of PPN neurons. For TSA (4 and 20 mg/kg), we observed reduced mean frequency of oscillations at gamma band and increased mean Rm of PPN neurons. Systemic administration of 20 mg/kg MC1568 and TSA effects on Rm were washed out after 60 min of in vitro incubation of PPN slices, suggesting an underlying functional recovery of PPN calcium-mediated gamma band oscillations over time. In addition, at a lower dose, 4 mg/kg, MC1568 and TSA induced higher mean amplitude gamma oscillations. Blocking HDAC class I might not have deleterious effects on gamma activity, but, more importantly, the inhibition of HDAC class I (at 100 mg/kg) increased gamma band oscillations. In conclusion, the present results in vivo validate our previous findings in vitro and further expand information on the effects of HDAC inhibition on PPN rhythmicity. PPN neurons require normal activity of HDAC class IIa in order to oscillate at gamma band.
Red arrows represent statistical significant inhibition. Blue arrows represent statistical significant enhancement. ~ Represents absence of change.Our findings suggest that gamma oscillations in the PPN are finely tuned in vivo by the activity of HDAC class IIa. Sustained blocking of HDAC IIa blunted gamma band oscillations of PPN neurons. Blocking HDAC class I showed higher gamma band amplitudes. In conclusion, systemic administration of HDAC inhibitors might have either negative or positive effects on PPN rhythmicity depending of dose and group of HDAC affected. [Display omitted]
•HDAC class IIa inhibitors (acutely, i.p.) blunted PPN oscillations at gamma band.•HDAC class I inhibitors (100 mg/kg; i.p.) increased PPN gamma band oscillations.•We suggest the existence of a physiological HDAC class I/IIa balance in the PPN.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2019.107922</identifier><identifier>PMID: 31923766</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Arousal ; Benzamides - administration & dosage ; Calcium channels. Calcium currents ; Female ; Gamma oscillations ; Gamma Rhythm - drug effects ; Histone Deacetylase Inhibitors - administration & dosage ; Histone Deacetylases - physiology ; Hydroxamic Acids - administration & dosage ; Male ; MC1568 ; Membrane Potentials - drug effects ; MS275 ; Neuroepigenetics ; Neurons - drug effects ; Neurons - physiology ; Pedunculopontine Tegmental Nucleus - drug effects ; Pedunculopontine Tegmental Nucleus - physiology ; Pyridines - administration & dosage ; Pyrroles - administration & dosage ; Rats, Sprague-Dawley ; Trichostatin A</subject><ispartof>Neuropharmacology, 2020-03, Vol.165, p.107922-107922, Article 107922</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763</citedby><cites>FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763</cites><orcidid>0000-0003-1367-3071</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31923766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bisagno, Veronica</creatorcontrib><creatorcontrib>Bernardi, Maria Alejandra</creatorcontrib><creatorcontrib>Sanz Blasco, Sara</creatorcontrib><creatorcontrib>Urbano, Francisco J.</creatorcontrib><creatorcontrib>Garcia-Rill, Edgar</creatorcontrib><title>Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The pedunculopontine nucleus (PPN) has long been known to be part of the reticular activating system (RAS) in charge of arousal and REM sleep. We previously showed that in vitro exposure to a HDAC Class I and II mixed inhibitor (TSA), or a specific HDAC class IIa inhibitor (MC 1568), decreased PPN gamma oscillations. Given the lack of information on systemic in vivo treatments on neuronal synaptic properties, the present study was designed to investigate the systemic effect of HDAC inhibitors (HDACi) on PPN rhythmicity. Rat pups were injected (acute, single dose) with TSA (4 or 20 mg/kg), MC1568 (4 or 20 mg/kg), or MS275 (20 or 100 mg/kg). Our results show that MC1568 (20 mg/kg) reduced mean frequency of PPN oscillations at gamma band, while increasing mean input resistance (Rm) of PPN neurons. For TSA (4 and 20 mg/kg), we observed reduced mean frequency of oscillations at gamma band and increased mean Rm of PPN neurons. Systemic administration of 20 mg/kg MC1568 and TSA effects on Rm were washed out after 60 min of in vitro incubation of PPN slices, suggesting an underlying functional recovery of PPN calcium-mediated gamma band oscillations over time. In addition, at a lower dose, 4 mg/kg, MC1568 and TSA induced higher mean amplitude gamma oscillations. Blocking HDAC class I might not have deleterious effects on gamma activity, but, more importantly, the inhibition of HDAC class I (at 100 mg/kg) increased gamma band oscillations. In conclusion, the present results in vivo validate our previous findings in vitro and further expand information on the effects of HDAC inhibition on PPN rhythmicity. PPN neurons require normal activity of HDAC class IIa in order to oscillate at gamma band.
Red arrows represent statistical significant inhibition. Blue arrows represent statistical significant enhancement. ~ Represents absence of change.Our findings suggest that gamma oscillations in the PPN are finely tuned in vivo by the activity of HDAC class IIa. Sustained blocking of HDAC IIa blunted gamma band oscillations of PPN neurons. Blocking HDAC class I showed higher gamma band amplitudes. In conclusion, systemic administration of HDAC inhibitors might have either negative or positive effects on PPN rhythmicity depending of dose and group of HDAC affected. [Display omitted]
•HDAC class IIa inhibitors (acutely, i.p.) blunted PPN oscillations at gamma band.•HDAC class I inhibitors (100 mg/kg; i.p.) increased PPN gamma band oscillations.•We suggest the existence of a physiological HDAC class I/IIa balance in the PPN.</description><subject>Animals</subject><subject>Arousal</subject><subject>Benzamides - administration & dosage</subject><subject>Calcium channels. Calcium currents</subject><subject>Female</subject><subject>Gamma oscillations</subject><subject>Gamma Rhythm - drug effects</subject><subject>Histone Deacetylase Inhibitors - administration & dosage</subject><subject>Histone Deacetylases - physiology</subject><subject>Hydroxamic Acids - administration & dosage</subject><subject>Male</subject><subject>MC1568</subject><subject>Membrane Potentials - drug effects</subject><subject>MS275</subject><subject>Neuroepigenetics</subject><subject>Neurons - drug effects</subject><subject>Neurons - physiology</subject><subject>Pedunculopontine Tegmental Nucleus - drug effects</subject><subject>Pedunculopontine Tegmental Nucleus - physiology</subject><subject>Pyridines - administration & dosage</subject><subject>Pyrroles - administration & dosage</subject><subject>Rats, Sprague-Dawley</subject><subject>Trichostatin A</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFUctOwzAQtBAIyuMXkI9cUvxSbF-QoDyKQMABzpbjbKirNC52Gql_j1F5njjZHs_O7s4ghCkZU0LL0_m4g1UMy5mNizEjVGdYasa20IgqyQtJSrGNRoQwVXBN1B7aT2lOCBGKql20x6lmXJblCN1d-qaBCF3vbYsh312fcGjw9PJ8gn0385XvQ8xQh5-eHnBIzretzdAaW9f7wffrTMODH8Ih2mlsm-Do8zxAL9dXz5Npcf94czs5vy-ckLovHJUanIKKKyugcrwSlW5q0E0jtVacaGBSVpo5Kkh-cKap0KJmdS1Ay5IfoLON7nJVLaB2efhoW7OMfmHj2gTrzd-fzs_MaxiMJEwLJrPAyadADG8rSL1Z-OQg79VBWCXDOC-ZKJUimao2VBdDShGa7zaUmI8szNz8ZGE-sjCbLHLp8e8xvwu_zM-Eiw0BslmDh2iyudA5qH3MMZg6-P-7vAOJXqF0</recordid><startdate>20200315</startdate><enddate>20200315</enddate><creator>Bisagno, Veronica</creator><creator>Bernardi, Maria Alejandra</creator><creator>Sanz Blasco, Sara</creator><creator>Urbano, Francisco J.</creator><creator>Garcia-Rill, Edgar</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1367-3071</orcidid></search><sort><creationdate>20200315</creationdate><title>Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo</title><author>Bisagno, Veronica ; Bernardi, Maria Alejandra ; Sanz Blasco, Sara ; Urbano, Francisco J. ; Garcia-Rill, Edgar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Arousal</topic><topic>Benzamides - administration & dosage</topic><topic>Calcium channels. Calcium currents</topic><topic>Female</topic><topic>Gamma oscillations</topic><topic>Gamma Rhythm - drug effects</topic><topic>Histone Deacetylase Inhibitors - administration & dosage</topic><topic>Histone Deacetylases - physiology</topic><topic>Hydroxamic Acids - administration & dosage</topic><topic>Male</topic><topic>MC1568</topic><topic>Membrane Potentials - drug effects</topic><topic>MS275</topic><topic>Neuroepigenetics</topic><topic>Neurons - drug effects</topic><topic>Neurons - physiology</topic><topic>Pedunculopontine Tegmental Nucleus - drug effects</topic><topic>Pedunculopontine Tegmental Nucleus - physiology</topic><topic>Pyridines - administration & dosage</topic><topic>Pyrroles - administration & dosage</topic><topic>Rats, Sprague-Dawley</topic><topic>Trichostatin A</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bisagno, Veronica</creatorcontrib><creatorcontrib>Bernardi, Maria Alejandra</creatorcontrib><creatorcontrib>Sanz Blasco, Sara</creatorcontrib><creatorcontrib>Urbano, Francisco J.</creatorcontrib><creatorcontrib>Garcia-Rill, Edgar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bisagno, Veronica</au><au>Bernardi, Maria Alejandra</au><au>Sanz Blasco, Sara</au><au>Urbano, Francisco J.</au><au>Garcia-Rill, Edgar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2020-03-15</date><risdate>2020</risdate><volume>165</volume><spage>107922</spage><epage>107922</epage><pages>107922-107922</pages><artnum>107922</artnum><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>The pedunculopontine nucleus (PPN) has long been known to be part of the reticular activating system (RAS) in charge of arousal and REM sleep. We previously showed that in vitro exposure to a HDAC Class I and II mixed inhibitor (TSA), or a specific HDAC class IIa inhibitor (MC 1568), decreased PPN gamma oscillations. Given the lack of information on systemic in vivo treatments on neuronal synaptic properties, the present study was designed to investigate the systemic effect of HDAC inhibitors (HDACi) on PPN rhythmicity. Rat pups were injected (acute, single dose) with TSA (4 or 20 mg/kg), MC1568 (4 or 20 mg/kg), or MS275 (20 or 100 mg/kg). Our results show that MC1568 (20 mg/kg) reduced mean frequency of PPN oscillations at gamma band, while increasing mean input resistance (Rm) of PPN neurons. For TSA (4 and 20 mg/kg), we observed reduced mean frequency of oscillations at gamma band and increased mean Rm of PPN neurons. Systemic administration of 20 mg/kg MC1568 and TSA effects on Rm were washed out after 60 min of in vitro incubation of PPN slices, suggesting an underlying functional recovery of PPN calcium-mediated gamma band oscillations over time. In addition, at a lower dose, 4 mg/kg, MC1568 and TSA induced higher mean amplitude gamma oscillations. Blocking HDAC class I might not have deleterious effects on gamma activity, but, more importantly, the inhibition of HDAC class I (at 100 mg/kg) increased gamma band oscillations. In conclusion, the present results in vivo validate our previous findings in vitro and further expand information on the effects of HDAC inhibition on PPN rhythmicity. PPN neurons require normal activity of HDAC class IIa in order to oscillate at gamma band.
Red arrows represent statistical significant inhibition. Blue arrows represent statistical significant enhancement. ~ Represents absence of change.Our findings suggest that gamma oscillations in the PPN are finely tuned in vivo by the activity of HDAC class IIa. Sustained blocking of HDAC IIa blunted gamma band oscillations of PPN neurons. Blocking HDAC class I showed higher gamma band amplitudes. In conclusion, systemic administration of HDAC inhibitors might have either negative or positive effects on PPN rhythmicity depending of dose and group of HDAC affected. [Display omitted]
•HDAC class IIa inhibitors (acutely, i.p.) blunted PPN oscillations at gamma band.•HDAC class I inhibitors (100 mg/kg; i.p.) increased PPN gamma band oscillations.•We suggest the existence of a physiological HDAC class I/IIa balance in the PPN.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31923766</pmid><doi>10.1016/j.neuropharm.2019.107922</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1367-3071</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2020-03, Vol.165, p.107922-107922, Article 107922 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7029427 |
source | ScienceDirect Journals |
subjects | Animals Arousal Benzamides - administration & dosage Calcium channels. Calcium currents Female Gamma oscillations Gamma Rhythm - drug effects Histone Deacetylase Inhibitors - administration & dosage Histone Deacetylases - physiology Hydroxamic Acids - administration & dosage Male MC1568 Membrane Potentials - drug effects MS275 Neuroepigenetics Neurons - drug effects Neurons - physiology Pedunculopontine Tegmental Nucleus - drug effects Pedunculopontine Tegmental Nucleus - physiology Pyridines - administration & dosage Pyrroles - administration & dosage Rats, Sprague-Dawley Trichostatin A |
title | Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T01%3A56%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20effects%20of%20HDAC%20inhibitors%20on%20PPN%20oscillatory%20activity%20in%20vivo&rft.jtitle=Neuropharmacology&rft.au=Bisagno,%20Veronica&rft.date=2020-03-15&rft.volume=165&rft.spage=107922&rft.epage=107922&rft.pages=107922-107922&rft.artnum=107922&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2019.107922&rft_dat=%3Cproquest_pubme%3E2336246880%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-c179ec8eb38a4ebc3b4b9fde9ff7998309e277b92c14009e3291494d2dd4e9763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2336246880&rft_id=info:pmid/31923766&rfr_iscdi=true |